AngioDynamics ROA 2010-2024 | ANGO
Current and historical return on assets (ROA) values for AngioDynamics (ANGO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| AngioDynamics ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-11-30 | $-0.23B | $0.29B | -73.23% |
| 2024-08-31 | $-0.24B | $0.29B | -67.64% |
| 2024-05-31 | $-0.18B | $0.32B | -44.96% |
| 2024-02-29 | $-0.19B | $0.33B | -41.47% |
| 2023-11-30 | $-0.01B | $0.50B | -2.51% |
| 2023-08-31 | $0.01B | $0.49B | 1.50% |
| 2023-05-31 | $-0.05B | $0.53B | -9.31% |
| 2023-02-28 | $-0.04B | $0.54B | -6.51% |
| 2022-11-30 | $-0.03B | $0.56B | -5.79% |
| 2022-08-31 | $-0.03B | $0.56B | -5.80% |
| 2022-05-31 | $-0.03B | $0.55B | -4.71% |
| 2022-02-28 | $-0.04B | $0.54B | -7.05% |
| 2021-11-30 | $-0.04B | $0.55B | -6.75% |
| 2021-08-31 | $-0.03B | $0.56B | -5.94% |
| 2021-05-31 | $-0.03B | $0.56B | -5.35% |
| 2021-02-28 | $-0.17B | $0.58B | -28.78% |
| 2020-11-30 | $-0.17B | $0.59B | -27.37% |
| 2020-08-31 | $-0.17B | $0.58B | -25.81% |
| 2020-05-31 | $-0.17B | $0.59B | -24.37% |
| 2020-02-29 | $0.05B | $0.73B | 6.57% |
| 2019-11-30 | $0.06B | $0.73B | 7.40% |
| 2019-08-31 | $0.06B | $0.69B | 7.90% |
| 2019-05-31 | $0.06B | $0.84B | 8.02% |
| 2019-02-28 | $0.01B | $0.78B | 0.68% |
| 2018-11-30 | $0.02B | $0.78B | 2.50% |
| 2018-08-31 | $0.02B | $0.69B | 2.29% |
| 2018-05-31 | $0.02B | $0.71B | 2.28% |
| 2018-02-28 | $0.00B | $0.70B | 0.14% |
| 2017-11-30 | $-0.01B | $0.70B | -1.42% |
| 2017-08-31 | $0.00B | $0.70B | 0.57% |
| 2017-05-31 | $0.01B | $0.71B | 0.70% |
| 2017-02-28 | $-0.03B | $0.70B | -3.49% |
| 2016-11-30 | $-0.03B | $0.71B | -3.70% |
| 2016-08-31 | $-0.04B | $0.73B | -5.53% |
| 2016-05-31 | $-0.04B | $0.73B | -5.71% |
| 2016-02-29 | $-0.00B | $0.75B | -0.13% |
| 2015-11-30 | $-0.01B | $0.76B | -0.78% |
| 2015-08-31 | $-0.01B | $0.77B | -0.64% |
| 2015-05-31 | $-0.00B | $0.77B | -0.51% |
| 2015-02-28 | $-0.01B | $0.78B | -0.63% |
| 2014-11-30 | $0.00B | $0.80B | 0.50% |
| 2014-08-31 | $0.00B | $0.80B | 0.38% |
| 2014-05-31 | $0.00B | $0.80B | 0.38% |
| 2014-02-28 | $0.00B | $0.79B | 0.50% |
| 2013-11-30 | $-0.00B | $0.80B | -0.25% |
| 2013-08-31 | $0.00B | $0.80B | 0.00% |
| 2013-05-31 | $-0.00B | $0.79B | -0.13% |
| 2013-02-28 | $-0.01B | $0.80B | -0.93% |
| 2012-11-30 | $-0.01B | $0.78B | -1.20% |
| 2012-08-31 | $-0.01B | $0.72B | -1.37% |
| 2012-05-31 | $-0.01B | $0.72B | -1.17% |
| 2012-02-29 | $0.00B | $0.45B | 0.00% |
| 2011-11-30 | $0.01B | $0.44B | 1.37% |
| 2011-08-31 | $0.01B | $0.44B | 1.61% |
| 2011-05-31 | $0.01B | $0.44B | 1.86% |
| 2011-02-28 | $0.01B | $0.43B | 3.05% |
| 2010-11-30 | $0.01B | $0.43B | 2.85% |
| 2010-08-31 | $0.01B | $0.42B | 2.88% |
| 2010-05-31 | $0.01B | $0.42B | 2.90% |
| 2010-02-28 | $0.01B | $0.41B | 2.69% |
| 2009-11-30 | $0.01B | $0.41B | 2.46% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.408B | $0.304B |
| AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $210.506B | 96.57 |
| Thermo Fisher Scientific (TMO) | United States | $202.042B | 24.50 |
| Alcon (ALC) | Switzerland | $44.047B | 29.47 |
| Edwards Lifesciences (EW) | United States | $42.914B | 27.77 |
| IDEXX Laboratories (IDXX) | United States | $37.709B | 43.46 |
| DexCom (DXCM) | United States | $35.463B | 55.00 |
| IQVIA Holdings (IQV) | United States | $34.295B | 19.00 |
| Mettler-Toledo (MTD) | United States | $27.400B | 31.83 |
| Waters (WAT) | United States | $22.520B | 31.95 |
| STERIS (STE) | Ireland | $21.977B | 25.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.361B | 0.00 |
| Hologic (HOLX) | United States | $14.588B | 15.74 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.679B | 14.04 |
| Sysmex ADR (SSMXY) | Japan | $11.343B | 35.57 |
| Penumbra (PEN) | United States | $11.081B | 100.24 |
| Globus Medical (GMED) | United States | $10.896B | 25.48 |
| Masimo (MASI) | United States | $9.140B | 44.23 |
| Teleflex (TFX) | United States | $8.250B | 13.16 |
| Glaukos (GKOS) | United States | $6.850B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.269B | 23.96 |
| PROCEPT BioRobotics (PRCT) | United States | $3.400B | 0.00 |
| Veracyte (VCYT) | United States | $3.050B | 55.44 |
| LivaNova (LIVN) | United Kingdom | $2.688B | 15.52 |
| Nihon Kohden (NHNKY) | Japan | $2.652B | 14.49 |
| TransMedics (TMDX) | United States | $2.588B | 82.04 |
| Elekta AB (EKTAY) | Sweden | $2.198B | 19.76 |
| Tandem Diabetes Care (TNDM) | United States | $2.145B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.701B | 8.89 |
| Alphatec Holdings (ATEC) | United States | $1.526B | 0.00 |
| RxSight (RXST) | United States | $1.181B | 0.00 |
| OPKO Health (OPK) | United States | $1.174B | 0.00 |
| Artivion (AORT) | United States | $1.167B | 111.40 |
| Pulse Biosciences (PLSE) | United States | $1.154B | 0.00 |
| Paragon 28 (FNA) | United States | $1.092B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.883B | 0.00 |
| AxoGen (AXGN) | United States | $0.793B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.791B | 17.30 |
| SiBone (SIBN) | United States | $0.733B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.718B | 12.21 |
| IRadimed (IRMD) | United States | $0.699B | 36.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.694B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.597B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.569B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.452B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.449B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.446B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.411B | 9.04 |
| NeuroPace (NPCE) | United States | $0.404B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.86 |
| CVRx (CVRX) | United States | $0.343B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.261B | 0.00 |
| Inogen (INGN) | United States | $0.234B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| Accuray (ARAY) | United States | $0.212B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.192B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.151B | 0.00 |
| Neuronetics (STIM) | United States | $0.135B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.125B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.121B | 0.00 |
| LENSAR (LNSR) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| InspireMD (NSPR) | Israel | $0.097B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.093B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.085B | 12.98 |
| Lucid Diagnostics (LUCD) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.081B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.58 |
| Microbot Medical (MBOT) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |